Development and characterization of complex DNA fingerprinting probes for the infectious yeast Candida dubliniensis.
about
MDR1-mediated drug resistance in Candida dubliniensisDifferentiation of Candida albicans and Candida dubliniensis by fluorescent in situ hybridization with peptide nucleic acid probes.Cloning and characterization of a complex DNA fingerprinting probe for Candida parapsilosis.The ins and outs of DNA fingerprinting the infectious fungiLongitudinal genotyping of Candida dubliniensis isolates reveals strain maintenance, microevolution, and the emergence of itraconazole resistance.Rapid identification of Candida dubliniensis with commercial yeast identification systems.Recovery of Candida dubliniensis from non-human immunodeficiency virus-infected patients in IsraelRapid identification of Candida dubliniensis using a species-specific molecular beacon.Novel 5-flucytosine-resistant clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprintingMolecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasisReplacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.Development and evaluation of a rapid latex agglutination test using a monoclonal antibody to identify Candida dubliniensis colonies.Extensive chromosome rearrangements distinguish the karyotype of the hypovirulent species Candida dubliniensis from the virulent Candida albicans.Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals.Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo.Molecular mechanisms of itraconazole resistance in Candida dubliniensis.Cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict susceptibility and resistance to ravuconazole among 12,796 clinical isolates of Candida sppComparison of Switching and Biofilm Formation between MTL-Homozygous Strains of Candida albicans and Candida dubliniensisPopulation structure and molecular genetic characterization of 5-flucytosine-susceptible and -resistant clinical Candida dubliniensis isolates from Kuwait.Multilocus sequence typing reveals that the population structure of Candida dubliniensis is significantly less divergent than that of Candida albicans.A Ser29Leu substitution in the cytosine deaminase Fca1p is responsible for clade-specific flucytosine resistance in Candida dubliniensisIdentification of Candida dubliniensis based on temperature and utilization of xylose and alpha-methyl-D-glucoside as determined with the API 20C AUX and vitek YBC systemsThe closely related species Candida albicans and Candida dubliniensis can mate.Racial distribution of Candida dubliniensis colonization among South Africans.Evaluation of a rapid immunochromatographic assay for identification of Candida albicans and Candida dubliniensis.Release of a potent polymorphonuclear leukocyte chemoattractant is regulated by white-opaque switching in Candida albicansUse of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods.Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression.
P2860
Q28364120-3D12BE96-5414-4CA3-B428-DF68F31225FEQ30757326-E4FB8D19-508F-49A0-A35F-14D51A5E842AQ31850229-D5EF376E-6477-47B9-995A-FBD8465BC5D4Q33555593-3339C726-5792-414A-B900-EE1F0E20EF62Q33827085-C43C4AD9-DB81-4E77-905F-19B873865D7BQ33963510-F871B9C5-C3D4-4C5D-87BD-9C9A06D1A5CAQ33964932-25F6E522-7089-41BE-A9D9-F7B676497959Q33968704-F803A45F-8D0F-4AB9-B242-609C09B9C0BBQ34041713-6381728A-42FD-4744-9818-9284979C1C5EQ34108536-72705D06-F18E-4C4A-B03C-CBD380F73029Q34195821-750AD104-8896-4807-BA2B-641B53D37D1AQ34315485-BBBF7054-33E2-4DA1-B4CC-6DDA67214686Q34667320-8ED736D0-C314-4778-9C3E-61DF933EA9B4Q34943566-67411BAE-9BDA-4FD7-BC97-39F96F6FDBB2Q34947163-9BF61D8B-06BB-48F2-811D-2A65C2180097Q35165969-C089269E-EC63-4D26-B7BD-84D483242CF5Q35714264-728E6A27-4904-4F36-8B91-1F26656B1C30Q36333319-1BDA6DB9-B0DA-4F4D-8F07-ABC4FDE9ED85Q36336204-54A534A3-5B97-4D9F-A504-B2B30FE41445Q36452663-4768CD29-8FA8-4456-A565-DB847A525A91Q37409933-1466AAE6-8731-48C3-AFCC-E7882C5CCD50Q39453684-DB94C49A-1943-4518-81BA-6B4D46D0CCE9Q39601440-91BF195F-A9F8-4072-B9D2-8584765BF460Q39751370-EC15FEAA-16A5-49A0-9EFC-3B4D94230E20Q40284763-CB740767-F220-4504-90DB-283C792707BCQ40469966-7E84C6D6-F3FF-4239-91D6-13F55CA5C2C6Q42071108-F40C65D0-26B2-4FA2-9DF8-7B68057B2D63Q42708818-5A32B27A-3C1C-4C34-BB7B-659F4411A98F
P2860
Development and characterization of complex DNA fingerprinting probes for the infectious yeast Candida dubliniensis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Development and characterizati ...... us yeast Candida dubliniensis.
@ast
Development and characterizati ...... us yeast Candida dubliniensis.
@en
type
label
Development and characterizati ...... us yeast Candida dubliniensis.
@ast
Development and characterizati ...... us yeast Candida dubliniensis.
@en
prefLabel
Development and characterizati ...... us yeast Candida dubliniensis.
@ast
Development and characterizati ...... us yeast Candida dubliniensis.
@en
P2093
P2860
P1476
Development and characterizati ...... ous yeast Candida dubliniensis
@en
P2093
P2860
P304
P407
P577
1999-04-01T00:00:00Z